Patent details
EP2307420 Title: NALMEFENE DI-ESTER PRODRUGS
Basic Information
- Publication number:
- EP2307420
- PCT Application Number:
- PCT/EP/2009/054875
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP097341614
- PCT Publication Number:
- WO/2009/130270
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- NALMEFENE DI-ESTER PRODRUGS
- French Title of Invention:
- PROMÉDICAMENTS DIESTERS DE NALMÉFÈNE
- German Title of Invention:
- NALMEFENDIESTERPRODRUGS
- SPC Number:
Dates
- Filing date:
- 23/04/2009
- Grant date:
- 30/11/2011
- EP Publication Date:
- 30/11/2011
- PCT Publication Date:
- 29/10/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/04/2011
- EP B1 Publication Date:
- 30/11/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 23/04/2023
- Expiration date:
- 23/04/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 23/04/2009
- Name:
- Janssen Pharmaceutica NV
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
Agent
- Name:
- ARONOVA S.A.
- From:
- 29/02/2012
- Address:
- PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
1
- Name:
- GUILLAUME Michel, Joseph, Maurice, André
- Address:
- Belgium (BE)
2
- Name:
- GAEKENS Tim
- Address:
- Belgium (BE)
Priority
- Priority Number:
- 08155092
- Priority Date:
- 24/04/2008
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- C07D 489/08;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 21/04/2022
- Last Annual Fee Paid Number:
- 14
- Last Annual Fee Paid Amount:
- 198 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|